Positive study results in 298 patients with obstructive sleep apnea (OSA)
15 March 2024
Desitin, an expert in neurological and psychiatric therapeutics, reports positive study results from the FLOW study with 298 patients: Nocturnal breathing pauses in patients with obstructive sleep apnea (OSA) were significantly reduced, thus meeting the primary endpoint of the study. With these positive results, a reliable basis for the final clinical phase 3 development of the first oral treatment for OSA has been established. While OSA has serious health implications, only around a third of all patients use the gold standard therapy of Continuous Positive Airway Pressure (CPAP) long-term.
Rapid pseudomonas aeruginosa detection method developed
15 March 2024
Research suggests the rapid detection method “will enable the timely implementation of microbiological monitoring strategies for large batches of medications”. Findings from an experimental study report the development of a rapid method for the detection of pseudomonas aeruginosa bacteria in medications.
Developing new treatment regimens for HIV
14 March 2024
Since the HIV epidemic began in the early 1980s, more than 85 million people have been diagnosed worldwide and about 40 million have died as a result of complications from the virus.1 Now, four decades later, 39 million people around the world are living with HIV, primarily due to advances in treatment.1 With continued innovation on the horizon in terms of prevention and treatment methods, what was once a wishful hope of ending the epidemic has become a conceivable goal.
Life sci marketing budgets boomed in 2023, led by spending on trade shows and websites, survey finds
14 March 2024
Marketing cut a bigger slice of the budgetary pie at life sciences companies in 2023, a recent survey has found. After several COVID-inflected years that saw companies allotting smaller percentages of their total revenues to marketing, 2023 ushered in a return nearly to pre-pandemic levels.
Metabolic disorders lab opens in Siberia
13 March 2024
A laboratory of experimental biochemistry and biology has been established at the Siberian State Medical University, where dedicated scientists will be pioneering the search for new markers to facilitate early disease detection, with a special focus on researching metabolic disorders. Here, they are planning to conduct research, develop and implement laboratory workshops and final qualification projects, as well as hold career guidance sessions for schoolchildren.
70% of drugs put into circulation in 2023 are Russian-made
12 March 2024
Previously, Russian media said that there is a medicine shortage in Russia. However, the Russian Ministry of Health denied the information. On the contrary, according to the Ministry, the situation on the domestic pharmaceutical market is stable.
Research into Cold Cancers Heating Up
12 March 2024
Wide-scale resources have increasingly been deployed to find, characterize, validate, bank, and file patents for cancer neoantigens. It has been a biological landgrab echoing the single nucleotide polymorphism (SNP) fervor at the turn of the century. In a conversation late in 2023 with Maravai’s chief innovation officer Kate Broderick and Accuitas’ CEO Tom Madden on future applications for messenger RNA (mRNA)-based therapeutics, the notion came up as a potential lynch pin.
EMA Expands Real-World Data Capacity
11 March 2024
The European Medicines Agency (EMA) announced on March 6, 2024 that the Data Analysis and Real World Interrogation Network, DARWIN EU, has plans to expand capacity for real-world data (RWD) studies in 2024 by adding 10 new data partners. The network currently includes 20 public or private institutions from 13 European countries with access to data from approximately 130 million patients in Europe.
Russia will send 10 million doses of veterinary vaccines to Mongolia
11 March 2024
The Federal State Budgetary Institution “Federal Center for Animal Health Protection” (FGBU “ARRIAH”) will help Mongolia in the fight against common animal diseases in the country. The decision on this was made during a meeting attended by representatives of the Main Veterinary Directorate of Mongolia.
Implications of AI regulation for data integrity
07 March 2024
According to research, organisations should invest in training for those working with artificial intelligence (AI) to support data integrity assurance in AI applications.
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Grand finale from a veritable stalwart of neuroscience
09 November 2023
Battle of pharma advocates – in search of the ideal migraine therapy
09 November 2023
Positive study results in 298 patients with obstructive sleep apnea (OSA)
15 March 2024
Rapid pseudomonas aeruginosa detection method developed
15 March 2024
Developing new treatment regimens for HIV
14 March 2024
Life sci marketing budgets boomed in 2023, led by spending on trade shows and websites, survey finds
14 March 2024